{"count": 1228, "results": [{"_id": "34053175", "pmid": 34053175, "pmcid": "PMC8278091", "title": "Metformin protects against insulin resistance induced by high uric acid in cardiomyocytes via AMPK signalling pathways in vitro and in vivo", "journal": "J Cell Mol Med", "authors": ["Jiao Z", "Chen Y", "Xie Y", "Li Y", "Li Z"], "date": "2021-07-01T00:00:00Z", "doi": "10.1111/jcmm.16677", "meta_date_publication": "2021 Jul", "meta_volume": "25", "meta_issue": "14", "meta_pages": "6733-6745", "score": 50280.13, "text_hl": "We investigated whether @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ protects against HUA-induced @<m>DISEASE_Insulin_Resistance</m> @DISEASE_MESH:D007333 @@@IR@@@ in cardiomyocytes. ", "citations": {"NLM": "Jiao Z, Chen Y, Xie Y, Li Y, Li Z. Metformin protects against insulin resistance induced by high uric acid in cardiomyocytes via AMPK signalling pathways in vitro and in vivo J Cell Mol Med. 2021 Jul;25(14):6733-6745. PMID: 34053175", "BibTeX": "@article{34053175, title={Metformin protects against insulin resistance induced by high uric acid in cardiomyocytes via AMPK signalling pathways in vitro and in vivo}, author={Jiao Z and Chen Y and Xie Y and Li Y and Li Z}, journal={J Cell Mol Med}, volume={25}, number={14}, pages={6733-6745}}"}}, {"_id": "34512303", "pmid": 34512303, "pmcid": "PMC8425557", "title": "Amelioration of Hippocampal Insulin Resistance Reduces Tau Hyperphosphorylation and Cognitive Decline Induced by Isoflurane in Mice", "journal": "Front Aging Neurosci", "authors": ["Peng L", "Fang X", "Xu F", "Liu S", "Qian Y", "Gong X", "Zhao X", "Ma Z", "Xia T", "Gu X"], "date": "2021-08-25T00:00:00Z", "doi": "10.3389/fnagi.2021.686506", "meta_date_publication": "2021", "meta_volume": "13", "meta_issue": "", "meta_pages": "686506", "score": 50276.418, "text_hl": "We further examined whether @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ can alleviate hippocampal @<m>DISEASE_Insulin_Resistance</m> @DISEASE_MESH:D007333 @@@IR@@@ and improve both tau hyperphosphorylation and pNR2B-Tyr1472 downregulation caused by long-term @CHEMICAL_Isoflurane @CHEMICAL_MESH:D007530 @@@isoflurane@@@ anesthesia. ", "citations": {"NLM": "Peng L, Fang X, Xu F, Liu S, Qian Y, Gong X, Zhao X, Ma Z, Xia T, Gu X. Amelioration of Hippocampal Insulin Resistance Reduces Tau Hyperphosphorylation and Cognitive Decline Induced by Isoflurane in Mice Front Aging Neurosci. 2021;13():686506. PMID: 34512303", "BibTeX": "@article{34512303, title={Amelioration of Hippocampal Insulin Resistance Reduces Tau Hyperphosphorylation and Cognitive Decline Induced by Isoflurane in Mice}, author={Peng L and Fang X and Xu F and Liu S and Qian Y and Gong X and Zhao X and Ma Z and Xia T and Gu X}, journal={Front Aging Neurosci}, volume={13}, pages={686506}}"}}, {"_id": "32606605", "pmid": 32606605, "pmcid": "PMC7306576", "title": "Metformin Decreases Insulin Resistance in Type 1 Diabetes Through Regulating p53 and RAP2A in vitro and in vivo", "journal": "Drug Des Devel Ther", "authors": ["Ren GF", "Xiao LL", "Ma XJ", "Yan YS", "Jiao PF"], "date": "2020-06-17T00:00:00Z", "doi": "10.2147/DDDT.S249557", "meta_date_publication": "2020", "meta_volume": "14", "meta_issue": "", "meta_pages": "2381-2392", "score": 50275.43, "text_hl": "...@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ is a common @<m>DISEASE_Insulin_Resistance</m> @DISEASE_MESH:D007333 @@@insulin sensitizer@@@. ", "citations": {"NLM": "Ren GF, Xiao LL, Ma XJ, Yan YS, Jiao PF. Metformin Decreases Insulin Resistance in Type 1 Diabetes Through Regulating p53 and RAP2A in vitro and in vivo Drug Des Devel Ther. 2020;14():2381-2392. PMID: 32606605", "BibTeX": "@article{32606605, title={Metformin Decreases Insulin Resistance in Type 1 Diabetes Through Regulating p53 and RAP2A in vitro and in vivo}, author={Ren GF and Xiao LL and Ma XJ and Yan YS and Jiao PF}, journal={Drug Des Devel Ther}, volume={14}, pages={2381-2392}}"}}, {"_id": "32454819", "pmid": 32454819, "pmcid": "PMC7231067", "title": " SLC22A1 rs622342 Polymorphism Predicts Insulin Resistance Improvement in Patients with Type 2 Diabetes Mellitus Treated with Metformin: A Cross-Sectional Study", "journal": "Int J Endocrinol", "authors": ["Wu K", "Li X", "Xu Y", "Zhang X", "Guan Z", "Zhang S", "Li Y"], "date": "2020-05-08T00:00:00Z", "doi": "10.1155/2020/2975898", "meta_date_publication": "2020", "meta_volume": "2020", "meta_issue": "", "meta_pages": "2975898", "score": 50274.855, "text_hl": "... @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ is the most widely used oral antidiabetic agent and can reduce @<m>DISEASE_Insulin_Resistance</m> @DISEASE_MESH:D007333 @@@insulin resistance@@@ (IR) effectively. ", "citations": {"NLM": "Wu K, Li X, Xu Y, Zhang X, Guan Z, Zhang S, Li Y.  SLC22A1 rs622342 Polymorphism Predicts Insulin Resistance Improvement in Patients with Type 2 Diabetes Mellitus Treated with Metformin: A Cross-Sectional Study Int J Endocrinol. 2020;2020():2975898. PMID: 32454819", "BibTeX": "@article{32454819, title={ SLC22A1 rs622342 Polymorphism Predicts Insulin Resistance Improvement in Patients with Type 2 Diabetes Mellitus Treated with Metformin: A Cross-Sectional Study}, author={Wu K and Li X and Xu Y and Zhang X and Guan Z and Zhang S and Li Y}, journal={Int J Endocrinol}, volume={2020}, pages={2975898}}"}}, {"_id": "37736515", "pmid": 37736515, "pmcid": "PMC10510480", "title": "Investigation of the effects of astaxanthin in experimental polycystic ovary syndrome (PCOS) in rats", "journal": "Iran J Basic Med Sci", "authors": ["Toktay E", "Selli J", "Gurbuz MA", "Alaca R"], "date": "2023-01-01T00:00:00Z", "doi": "10.22038/IJBMS.2023.69984.15223", "meta_date_publication": "2023", "meta_volume": "26", "meta_issue": "10", "meta_pages": "1155-1161", "score": 50274.7, "text_hl": "@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ improved @DISEASE_Polycystic_Ovary_Syndrome @DISEASE_MESH:D011085 @@@PCOS@@@ by correcting @<m>DISEASE_Insulin_Resistance</m> @DISEASE_MESH:D007333 @@@insulin resistance@@@. ", "citations": {"NLM": "Toktay E, Selli J, Gurbuz MA, Alaca R. Investigation of the effects of astaxanthin in experimental polycystic ovary syndrome (PCOS) in rats Iran J Basic Med Sci. 2023;26(10):1155-1161. PMID: 37736515", "BibTeX": "@article{37736515, title={Investigation of the effects of astaxanthin in experimental polycystic ovary syndrome (PCOS) in rats}, author={Toktay E and Selli J and Gurbuz MA and Alaca R}, journal={Iran J Basic Med Sci}, volume={26}, number={10}, pages={1155-1161}}"}}, {"_id": "34907435", "pmid": 34907435, "pmcid": "PMC8888993", "title": "Effect of acupuncture and metformin on insulin sensitivity in women with polycystic ovary syndrome and insulin resistance: a three-armed randomized controlled trial", "journal": "Hum Reprod", "authors": ["Wen Q", "Hu M", "Lai M", "Li J", "Hu Z", "Quan K", "Liu J", "Liu H", "Meng Y", "Wang S", "Wen X", "Yu C", "Li S", "Huang S", "Zheng Y", "Lin H", "Liang X", "Lu L", "Mai Z", "Zhang C", "Wu T", "Ng EHY", "Stener-Victorin E", "Ma H"], "date": "2022-03-01T00:00:00Z", "doi": "10.1093/humrep/deab272", "meta_date_publication": "2022 Mar 1", "meta_volume": "37", "meta_issue": "3", "meta_pages": "542-552", "score": 50272.465, "text_hl": "Effect of acupuncture and @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ on @GENE_INS @GENE_3630 @@@insulin@@@ sensitivity in @SPECIES_9606 @@@women@@@ with @DISEASE_Polycystic_Ovary_Syndrome @DISEASE_MESH:D011085 @@@polycystic ovary syndrome@@@ and @<m>DISEASE_Insulin_Resistance</m> @DISEASE_MESH:D007333 @@@insulin resistance@@@: a three-armed randomized controlled trial", "citations": {"NLM": "Wen Q, Hu M, Lai M, Li J, Hu Z, Quan K, Liu J, Liu H, Meng Y, Wang S, Wen X, Yu C, Li S, Huang S, Zheng Y, Lin H, Liang X, Lu L, Mai Z, Zhang C, Wu T, Ng EHY, Stener-Victorin E, Ma H. Effect of acupuncture and metformin on insulin sensitivity in women with polycystic ovary syndrome and insulin resistance: a three-armed randomized controlled trial Hum Reprod. 2022 Mar 1;37(3):542-552. PMID: 34907435", "BibTeX": "@article{34907435, title={Effect of acupuncture and metformin on insulin sensitivity in women with polycystic ovary syndrome and insulin resistance: a three-armed randomized controlled trial}, author={Wen Q and Hu M and Lai M and Li J and Hu Z and Quan K and Liu J and Liu H and Meng Y and Wang S and Wen X and Yu C and Li S and Huang S and Zheng Y and Lin H and Liang X and Lu L and Mai Z and Zhang C and Wu T and Ng EHY and Stener-Victorin E and Ma H}, journal={Hum Reprod}, volume={37}, number={3}, pages={542-552}}"}}, {"_id": "35163187", "pmid": 35163187, "pmcid": "PMC8836112", "title": "Metformin and Insulin Resistance: A Review of the Underlying Mechanisms behind Changes in GLUT4-Mediated Glucose Transport", "journal": "Int J Mol Sci", "authors": ["Herman R", "Kravos NA", "Jensterle M", "Janež A", "Dolžan V"], "date": "2022-01-23T00:00:00Z", "doi": "10.3390/ijms23031264", "meta_date_publication": "2022 Jan 23", "meta_volume": "23", "meta_issue": "3", "meta_pages": "", "score": 50272.062, "text_hl": "@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ and @<m>DISEASE_Insulin_Resistance</m> @DISEASE_MESH:D007333 @@@Insulin Resistance@@@: A Review of the Underlying Mechanisms behind Changes in @GENE_SLC2A4 @GENE_6517 @@@GLUT4@@@-Mediated @CHEMICAL_Glucose @CHEMICAL_MESH:D005947 @@@Glucose@@@ Transport", "citations": {"NLM": "Herman R, Kravos NA, Jensterle M, Janež A, Dolžan V. Metformin and Insulin Resistance: A Review of the Underlying Mechanisms behind Changes in GLUT4-Mediated Glucose Transport Int J Mol Sci. 2022 Jan 23;23(3):. PMID: 35163187", "BibTeX": "@article{35163187, title={Metformin and Insulin Resistance: A Review of the Underlying Mechanisms behind Changes in GLUT4-Mediated Glucose Transport}, author={Herman R and Kravos NA and Jensterle M and Janež A and Dolžan V}, journal={Int J Mol Sci}, volume={23}, number={3}}"}}, {"_id": "37901890", "pmid": 37901890, "pmcid": "PMC10604500", "title": "Insulin Resistance in Adolescents and Youth With Type 1 Diabetes: A Review of Problems and Solutions", "journal": "Clin Med Insights Endocrinol Diabetes", "authors": ["Khadilkar A", "Oza C", "Mondkar SA"], "date": "2023-10-26T00:00:00Z", "doi": "10.1177/11795514231206730", "meta_date_publication": "2023", "meta_volume": "16", "meta_issue": "", "meta_pages": "11795514231206730", "score": 50271.035, "text_hl": "The mean improvement in @<m>DISEASE_Insulin_Resistance</m> @DISEASE_MESH:D007333 @@@IS@@@ ranged from 1.4% to 4.6% in participants on @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ as opposed to deterioration of -2% to -14.1% in the non-@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ group. ", "citations": {"NLM": "Khadilkar A, Oza C, Mondkar SA. Insulin Resistance in Adolescents and Youth With Type 1 Diabetes: A Review of Problems and Solutions Clin Med Insights Endocrinol Diabetes. 2023;16():11795514231206730. PMID: 37901890", "BibTeX": "@article{37901890, title={Insulin Resistance in Adolescents and Youth With Type 1 Diabetes: A Review of Problems and Solutions}, author={Khadilkar A and Oza C and Mondkar SA}, journal={Clin Med Insights Endocrinol Diabetes}, volume={16}, pages={11795514231206730}}"}}, {"_id": "38131036", "pmid": 38131036, "pmcid": "PMC10735721", "title": "Action Mechanisms of Metformin Combined with Exenatide and Metformin Only in the Treatment of PCOS in Obese Patients", "journal": "Int J Endocrinol", "authors": ["Gan J", "Chen J", "Ma RL", "Deng Y", "Ding XS", "Zhu SY", "Sun AJ"], "date": "2023-12-14T00:00:00Z", "doi": "10.1155/2023/4288004", "meta_date_publication": "2023", "meta_volume": "2023", "meta_issue": "", "meta_pages": "4288004", "score": 50270.215, "text_hl": "Some clinical studies comparing @GENE_GCG @GENE_24952 @@@GLP-1@@@ RA with @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ showed that the former has advantages in improving body weight, HOMA-@<m>DISEASE_Insulin_Resistance</m> @DISEASE_MESH:D007333 @@@IR@@@, menstrual frequency, and spontaneous pregnancy rate. ", "citations": {"NLM": "Gan J, Chen J, Ma RL, Deng Y, Ding XS, Zhu SY, Sun AJ. Action Mechanisms of Metformin Combined with Exenatide and Metformin Only in the Treatment of PCOS in Obese Patients Int J Endocrinol. 2023;2023():4288004. PMID: 38131036", "BibTeX": "@article{38131036, title={Action Mechanisms of Metformin Combined with Exenatide and Metformin Only in the Treatment of PCOS in Obese Patients}, author={Gan J and Chen J and Ma RL and Deng Y and Ding XS and Zhu SY and Sun AJ}, journal={Int J Endocrinol}, volume={2023}, pages={4288004}}"}}, {"_id": "37635987", "pmid": 37635987, "pmcid": "PMC10449574", "title": "Metformin combined with spironolactone vs. metformin alone in polycystic ovary syndrome: a meta-analysis", "journal": "Front Endocrinol (Lausanne)", "authors": ["Zeng H", "Zhang Y", "Huang S", "Wu J", "Ren W", "Zhou L", "Huang L", "Ye Y"], "date": "2023-08-10T00:00:00Z", "doi": "10.3389/fendo.2023.1223768", "meta_date_publication": "2023", "meta_volume": "14", "meta_issue": "", "meta_pages": "1223768", "score": 50269.605, "text_hl": "Moreover, when the treatment course was greater than 6 months, combination therapy reduced FBG and improved @<m>DISEASE_Insulin_Resistance</m> @DISEASE_MESH:D007333 @@@insulin resistance@@@ more effectively than @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ alone. ", "citations": {"NLM": "Zeng H, Zhang Y, Huang S, Wu J, Ren W, Zhou L, Huang L, Ye Y. Metformin combined with spironolactone vs. metformin alone in polycystic ovary syndrome: a meta-analysis Front Endocrinol (Lausanne). 2023;14():1223768. PMID: 37635987", "BibTeX": "@article{37635987, title={Metformin combined with spironolactone vs. metformin alone in polycystic ovary syndrome: a meta-analysis}, author={Zeng H and Zhang Y and Huang S and Wu J and Ren W and Zhou L and Huang L and Ye Y}, journal={Front Endocrinol (Lausanne)}, volume={14}, pages={1223768}}"}}]}